U.S. Ends AIDS Immigration Discrimination
For 22 years, people with HIV and AIDS have been banned from entering the U.S. It's pretty difficult to throw a global AIDS conference under such circumstances, which is why the policy is coming to an end.
For 22 years, people with HIV and AIDS have been banned from entering the U.S. It’s pretty difficult to throw a global AIDS conference under such circumstances, which is why the policy is coming to an end.
The ban kept the U.S. in awkward company. Saudi Arabia and Libya have similar immigration rules. — PZS
Your support is crucial…BBC:
Rachel Tiven, head of the campaign group Immigration Equality, told the BBC that the step was long overdue.
“The 2012 World Aids Conference, due to be held in the United States, was in jeopardy as a result of the restrictions. It’s now likely to go ahead as planned,” she said.
In October, President Obama said the entry ban had been “rooted in fear rather than fact”.
With an uncertain future and a new administration casting doubt on press freedoms, the danger is clear: The truth is at risk.
Now is the time to give. Your tax-deductible support allows us to dig deeper, delivering fearless investigative reporting and analysis that exposes what’s really happening — without compromise.
Stand with our courageous journalists. Donate today to protect a free press, uphold democracy and unearth untold stories.
Health & Wellness
Aging with HIV comes with an increased risk of health complications later in life. Is the U.S. health care system prepared to treat this growing population?
Opinion
A HIV survivor and former instructor reflects on his experiences.
The 40th president, though he proved to be less extreme than his campaign promises, ignited a wide transformation that resounds to this day.
In 2017, almost 16,000 people died from complications of the virus.
Pundits and politicians have transformed the 41st president into a paragon of virtue. All it took was a willful ignorance of history.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.